Cargando…
Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189382/ https://www.ncbi.nlm.nih.gov/pubmed/36322823 http://dx.doi.org/10.1182/bloodadvances.2022008574 |
| _version_ | 1785043074611675136 |
|---|---|
| author | Gelbenegger, Georg Jäger, Ulrich Fillitz, Michael Schörgenhofer, Christian Sillaber, Christian Jilma, Bernd |
| author_facet | Gelbenegger, Georg Jäger, Ulrich Fillitz, Michael Schörgenhofer, Christian Sillaber, Christian Jilma, Bernd |
| author_sort | Gelbenegger, Georg |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10189382 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101893822023-05-18 Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease Gelbenegger, Georg Jäger, Ulrich Fillitz, Michael Schörgenhofer, Christian Sillaber, Christian Jilma, Bernd Blood Adv Research Letter The American Society of Hematology 2022-11-04 /pmc/articles/PMC10189382/ /pubmed/36322823 http://dx.doi.org/10.1182/bloodadvances.2022008574 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Gelbenegger, Georg Jäger, Ulrich Fillitz, Michael Schörgenhofer, Christian Sillaber, Christian Jilma, Bernd Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease |
| title | Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease |
| title_full | Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease |
| title_fullStr | Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease |
| title_full_unstemmed | Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease |
| title_short | Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease |
| title_sort | sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189382/ https://www.ncbi.nlm.nih.gov/pubmed/36322823 http://dx.doi.org/10.1182/bloodadvances.2022008574 |
| work_keys_str_mv | AT gelbeneggergeorg sustainedhematologicremissionafterdiscontinuationofsutimlimabtreatmentinpatientswithcoldagglutinindisease AT jagerulrich sustainedhematologicremissionafterdiscontinuationofsutimlimabtreatmentinpatientswithcoldagglutinindisease AT fillitzmichael sustainedhematologicremissionafterdiscontinuationofsutimlimabtreatmentinpatientswithcoldagglutinindisease AT schorgenhoferchristian sustainedhematologicremissionafterdiscontinuationofsutimlimabtreatmentinpatientswithcoldagglutinindisease AT sillaberchristian sustainedhematologicremissionafterdiscontinuationofsutimlimabtreatmentinpatientswithcoldagglutinindisease AT jilmabernd sustainedhematologicremissionafterdiscontinuationofsutimlimabtreatmentinpatientswithcoldagglutinindisease |